

| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Gabapentin | FAERS: 1 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 3 | Norgestrel | FAERS: 1 | US FAERS | |
| 4 | NuvaRing | FAERS: 1 | US FAERS | |
| 5 | Risedronic Acid | FAERS: 1 | US FAERS | |
| 6 | Sulfamethoxazole | FAERS: 1 | US FAERS | |
| 7 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 8 | empagliflozin | FAERS: 1 | US FAERS | |
| 9 | etonogestrel | FAERS: 1 | US FAERS | |
| 10 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 11 | Cimetidine | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Cyclophosphamide | 2231904 10637075 | CTD | |
| 13 | naratriptan | SIDER | ||
| 14 | reviparin | 1255900 | CTD |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.